Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trafermin Safety in Periodontal Surgery
NCT01015404Phase 3Completed
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Nov 2009
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of trafermin in periodontitis, sponsored by Kaken Pharmaceutical Co., Ltd.. Started Nov 2009; status: completed.
02
Drugs
trafermin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT01015404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015404.